Nosocomial infection

From April 1^st, 2015, to March 31^st, 2016, 45 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 54,717 patient-periods (Table 1), slightly less than the preceding year. Participating units reported 136 VARBSIs in 129 patients. Patient-periods involving a fistula account for 41.0% of patient-periods. The 2015-2016…

From April 1^st, 2015, to March 31^st, 2016, 66 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 128,035 catheter-days (Table 1). Participating ICUs reported 150 CLABSIs in 139 patients. Incidence rates are 0.70 per 1,000 catheter-days in teaching adult ICUs, 0.42 in non-teaching adult ICUs, 1.95 in pediatric ICUs and 4.15 in neonatal ICUs…

From April 1^st, 2015, to March 31^st, 2016, 87 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,770,053 patient-days (Table 1). Participating facilities reported 3,173 BSIs in 2,948 patients. The total 2015-2016 incidence rate is 5.45 cases per 10,000 patient-days for all facilities participating in 2015-2016, and it is 5.35 for facilities…

From April 1, 2015, to March 31, 2016, 95 healthcare facilities participated in the Clostridium difficile–associated diarrhea (CDAD) surveillance program, for a combined total of 5,048,411 inpatient days (Table 1). These participating facilities reported 2,977 cases of healthcare-associated CDAD (HA-CDAD). The incidence rate of HA-CDAD was 5.9 cases per 10,000 patient days. The 2015-2016 incidence rate was significantly lower than……

From April 1, 2015, to March 31, 2016, 73 healthcare facilities took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 3,749,277 patient days (Table 1). In total, four CPGNB infections were reported among patients who acquired their strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated CPGNB infection (cat. 1a and 1b) was 0.011 per 10,000…

From April 1, 2015, to March 31, 2016, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,833,086 patient days (Table 1). In total, 78 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated VRE infection (cat. 1a and 1b) was 0.16 per 10…

From April 1, 2015, to March 31, 2016, 89 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,851,752 inpatient days (Table 1). Together, these facilities reported 65 cases of healthcare-associated MRSA bloodstream infections (HA-MRSA-BSI). The incidence rate was 0.13 per 10,000 patient-days. This incidence rate of HA-MRSA-BSI has……

In 2010, the Comité sur les infections nosocomiales du Québec (CINQ) [Québec healthcare-associated infections committee] released its guidelines for preventing and controlling transmission of carbapenemase-producing Enterobacteriaceae, and then more recently, in 2015, its measures to prevent and control transmission of multidrug-resistant Gram-negative bacilli (MDR-GNB) in acute care settings.

The application of infection prevention and control (IPC) measures in long-term care…

From April 1, 2015, to March 31, 2016, 73 healthcare facilities took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 3,749,277 patient days (Table 1). In total, four CPGNB infections were reported among patients who acquired their strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated CPGNB infection (cat. 1a and 1b) was 0.011 per 10,000…

From April 1^st, 2015, to March 31^st, 2016, 45 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 54,717 patient-periods (Table 1), slightly less than the preceding year. Participating units reported 136 VARBSIs in 129 patients. Patient-periods involving a fistula account for 41.0% of patient-periods. The 2015-2016…